Yuanbao Inc. – Sponsored ADR (NASDAQ:YB – Get Free Report) gapped down prior to trading on Tuesday. The stock had previously closed at $12.94, but opened at $12.50. Yuanbao shares last traded at $12.55, with a volume of 550 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings upgraded shares of Yuanbao from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 5th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $21.80.
View Our Latest Report on Yuanbao
Yuanbao Trading Down 1.2%
Yuanbao (NASDAQ:YB – Get Free Report) last released its quarterly earnings results on Friday, September 11th. The company reported $1.26 EPS for the quarter. Yuanbao had a net margin of 29.91% and a return on equity of 43.75%. The company had revenue of $204.92 million for the quarter.
Institutional Investors Weigh In On Yuanbao
An institutional investor recently bought a new stake in Yuanbao stock. Ramsey Quantitative Systems purchased a new stake in Yuanbao Inc. – Sponsored ADR (NASDAQ:YB – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 10,489 shares of the company’s stock, valued at approximately $160,000. Yuanbao comprises 0.1% of Ramsey Quantitative Systems’ investment portfolio, making the stock its 26th biggest holding.
Yuanbao Company Profile
Yuanbao Inc (NASDAQ: YB) is a China-based insurance technology company that operates a digital platform for the distribution of insurance products. The company uses online tools and data-driven technology to connect consumers with insurance coverage and support insurance agents in serving customers.
Yuanbao’s business primarily focuses on life and health insurance products, along with other types of coverage available through its platform. Its services are designed to help users learn about insurance options, compare products, complete applications and receive policy-related support.
See Also
- Five stocks we like better than Yuanbao
- Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- Why onsemi’s Synaptics Pivot Could Be a Game Changer
- AI Chip Demand Gives Linde a New Growth Catalyst
- Qualcomm’s Huawei Deal Adds Strategic Depth to Its AI Expansion
Receive News & Ratings for Yuanbao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yuanbao and related companies with MarketBeat.com's FREE daily email newsletter.
